Patent Assignment
Reel/Frame 029557/0771
Security Agreement
Recorded: 2012-12-31
Pages: 20
Assignor
SIGA TECHNOLOGIES, INC.
Executed: 2012-12-31
Assignee
GE CAPITAL EQUITY INVESTMENTS, INC. C/O GE HEALTHCARE FINANCIAL SERVICES, INC.
TWO BETHESDA METRO CENTER, SUITE 600, BETHESDA, MARYLAND, 20814
Covered Properties
(23)
Sulfonyl Semicarbazides, Carbonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Antiviral Drugs for Treatment of Arenavirus Infection
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Antiviral Drugs for Treatment of Arenavirus Infection
Anti-Arenaviral Compounds
Antiviral Drugs for Treatment of Arenavirus Infection
Antiviral Drugs for Treatment or Prevention of Dengue Infection
Antiviral Drugs for Treatment of Arenavirus Infection
Antiviral Drugs for Treatment of Arenavirus Infection
Small Molecule Inhibitors for the Treatment or Prevention of Dengue Virus Infection
Anti-Viral Drugs for Treatment of Arenavirus Infection
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arenaviruses
Sulfonyl semicarbazides, semicarbazides and ureas, pharmaceutical compositions thereof, and methods for treating hemorrhagic fever viruses, including infections associated with arenaviruses
Sulfonyl Semicarbazides, Semicarbazides and Ureas, Pharmaceutical Compositions Thereof, and Methods for Treating Hemorrhagic Fever Viruses, Including Infections Associated with Arena Viruses
Thienopyridine Derivatives for the Treatment and Prevention of Dengue Virus Infections
Antiviral Drugs for Treatment of Arenavirus Infection
Anti-Arenaviral Compounds
Anti-Arenaviral Compounds
Treatment and Prevention of Dengue Virus Infections
Antiviral Drugs for Treatment of Arenavirus Infection
Antiviral Drugs for Treatment of Arenavirus Infection
Inhibitors and Methods of Inhibiting Bacterial and Viral Pathogens
Antiviral Drugs for Treatment of Arenavirus Infection
Application:
61/600,036 →
Related Assignments
(14)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest
Jan 26, 2010
From: BYRD, CHELSEA M.; JORDAN, ROBERT; DAI, DONGCHENG; BOLKEN, TOVE
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 023845/0476 →
Assignment of Assignor's Interest
Feb 28, 2011
From: BYRD, CHELSEA M.; JORDAN, ROBERT; DAI, DONGCHENG; HRUBY, DENNIS E.
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 025869/0552 →
Confirmatory License
Jul 17, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 028571/0641 →
Confirmatory License
Oct 18, 2012
From: SIGA TECHNOLOGIES, INC.
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 029151/0189 →
Release of Security Interest
Aug 14, 2014
From: GENERAL ELECTRIC CAPITAL CORPORATION
To: SIGA TECHNOLOGIES INC.
Reel/Frame 033544/0324 →
Assignment of Assignor's Interest
Aug 22, 2014
From: SIGA TECHNOLOGIES INC.
To: KINETA FOUR LLC
Reel/Frame 033588/0427 →
Release of Security Interest
Apr 2, 2015
From: GENERAL ELECTRIC CAPITAL CORPORATION, AS AGENT
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 035319/0001 →
Security Interest
Nov 16, 2016
From: SIGA TECHNOLOGIES, INC.
To: CORTLAND CAPITAL MARKET SERVICES, LLC
Reel/Frame 040349/0219 →
Release of Security Interest in Intellectual Property at Reel/Frame No. 40349/0219
Mar 13, 2020
From: CORTLAND CAPITAL MARKET SERVICES LLC
To: SIGA TECHNOLOGIES, INC.
Reel/Frame 052163/0014 →
Confirmatory License
May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0611 →
Confirmatory License
May 29, 2020
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 052796/0609 →
Confirmatory License
Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0736 →
Confirmatory License
Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0766 →
Confirmatory License
Jun 17, 2021
From: SIGA TECHNOLOGIES INC
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 056615/0656 →